About Us: CMDB is a cross-disciplinary theme at a leading research University in the sunny south, consisting of a diverse group of scientists and physicians who have a collective interest in fundamental processes in cell, molecular, and developmental biology and how alterations in these processes result inhuman diseases and birth defects.
About UAB: We are consistently one of the top 25 NIH funded research institutions in the U.S. and with faculty from over 30 departments across campus there are many opportunities for you in new and exciting areas of biomedical research. And, UAB is a leader in innovative technology such as whole genome sequencing, electron microscopy, mass spectrometry, crystallography, flow cytometry, drug discovery and others.
Contact Us: We are always searching for the brightest and most dedicated students to join our highly competitive CMDB theme and experience firsthand our cutting edge science. This is your personal invitation to explore the many possible opportunities offered by CMDB at UAB. Please explore this web site and apply today!
The UAB studies are designed to test the safety and tolerability of CBD oil in patients with intractable seizures. CBD oil, a derivative of the cannabis plant, is delivered orally as an oily liquid.The University of Alabama at Birmingham has launched two studies of cannabidiol oil, or CBD oil, as a treatment for severe, intractable seizures. The two studies, an adult study at UAB and a pediatric study at Children’s of Alabama, were authorized by the Alabama Legislature in 2014 by legislation known as Carly’s Law. The UAB studies are designed to test the safety and tolerability of CBD oil in patients with intractable seizures. CBD oil, a derivative of the cannabis plant, is delivered orally as an oily liquid. “We are extremely pleased to launch these exciting studies,” said David Standaert, M.D., Ph.D., chair of the Department of Neurology. “What we learn from these investigations could have a profound impact on...
William S. Tuten, O.D., Ph.D., will present on the use of adaptive optics ophthalmoscopes to increase understanding of photoreceptor cells.The University of Alabama at Birmingham School of Optometry will host William S. Tuten, O.D., Ph.D., clinical scientist, University of California, Berkeley Vision Science Program, as its visiting scholar. Tuten will present “Using adaptive optics to study structure and function at the cellular scale in retinal disease” at noon Monday, March 2, in the Worrell Conference Room in the Henry Peters Building, 1716 University Blvd. The seminar will discuss the use of adaptive optics ophthalmoscopes to capture images of the human retina during the past two decades. This gave scientists unprecedented access into individual photoreceptor cells and increased the understanding of their structure in normal eyes and in those with retinal disease.
National Institute of Nursing Research’s five-year grant is for ENABLE: CHF-PC study to determine whether palliative care is a best practice for heart-failure patients.University of Alabama at Birmingham School of Nursing professor and Marie L. O’Koren Endowed Chair Marie Bakitas, DNSc, has received a five-year, $3.5 million R01 grant from the National Institute of Nursing Research for a study to determine whether palliative care provided when advanced heart-failure patients are still well will result in better quality of life, improved mood, and less symptom distress/burden for patients and/or caregivers, when compared to usual heart-failure care. This National Institutes of Health randomized controlled trial, “ENABLE: CHF-PC (Educate, Nurture, Advise Before Life Ends: Comprehensive Heartcare for Patients and Caregivers),” will compare the quality of life, symptom burden and mood in 380 older adults with stage III/IV heart failure and their family caregivers. Half of the patient participants will be randomized to the intervention,...